Proactive Investors - Run By Investors For Investors
Market: ASX
52-week High/Low: A$101.00 / A$70.19
Sector: Pharma & Biotech
Market Cap: A$46,448.30M
CSL Limited

CSL Limited

CSL Limited is a biopharmaceutical company engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. It operates in one segment, Human Health, which develops, manufactures and markets biopharmaceutical products to the human health industry.

Deal CSL Tax Free* Losses can exceed
your initial deposit
*subject to change and depends on individual circumstances.

CSL Limited

Interactive graph

col 3
col 4
col 5
col 6

© Proactive Investors 2015

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.